HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TFX

Teleflex Incorporated (S&P 500)

Healthcare — Medical Instruments & Supplies

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Buy 2.5 / 5 11 analysts
$134.20
+$3.15 (+2.40%)
Target: $147.45 (9.9%)
Sign in to add TFX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$5.94B
P/E Ratio (TTM)1917.14
Forward P/E12.68
EPS (TTM)$0.07
Dividend Yield1.04%
Profit Margin-47.43%
Revenue Growth32.30%
ROE0.04%
Debt/Equity88.79
Recommendation Buy 2.5
Analyst Target$147.45
Analysts11
Indexes S&P 500

Technical Indicators

RSI (14)56.8
Beta0.82
SMA 20$132.95
SMA 40$130.73
52-Week High$139.67
52-Week Low$100.18
50-Day Avg$130.76
200-Day Avg$120.91
Avg Volume585.0K
Volume306.0K

Performance Analysis

BULLISH

TFX shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 86% of its 52-week range.
+ RSI at 56.8 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 1917.1 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 32.3% year-over-year.
- Operating at a loss with -47.4% margin.
+ Wall Street consensus is "Buy" from 11 analysts.
+ Average analyst target of $147.45 implies 9.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:01 UTC

Back to Screener Export Report